Table 2.

Comparison between the main characteristics patients who received ¹³¹I therapy and those who did not.

	131I therapy   (N = 45)	No 131I therapy   (N = 46)	P
Age (years)	46.07 ± 12.07	49.35 ± 14.5	0.54
Male gender (%)	20	15.2	0.59
Tumour size (cm)	0.48 ± 0.24	0.41 ± 0.24	0.71
Multifocality (%)	48.9	13	0.04
T1 with capsular invasion (%)	2.2	0	0.49
Ganglionar disease (%)	6.7	2.2	0.36
Distant metastasis (%)	2.2	0	0.48